PLoS ONE (Jan 2019)

Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.

  • Georgios Batsos,
  • Eleni Christodoulou,
  • Georgios Vartholomatos,
  • Petros Galanis,
  • Maria Stefaniotou

DOI
https://doi.org/10.1371/journal.pone.0227266
Journal volume & issue
Vol. 14, no. 12
p. e0227266

Abstract

Read online

PURPOSE:To measure vitreous levels of Lipocalin2 (LCN2) in patients with rhegmatogenous retinal detachment (RRD) and investigate potential association with presence of proliferative vitreoretinopathy (PVR). MATERIALS AND METHODS:Collection of undiluted vitreous samples from 24 patients suffering from RRD and 10 control patients undergoing vitrectomy for: vitreomacular traction (VMT) (n = 2), idiopathic epiretinal membrane (iERM) (n = 6) and full thickness macular hole (FTMH) (n = 2). Quantitative analysis of LCN2 has been made with flow cytometry. Lens status, duration of symptoms, quadrants of detachment, as well as level of PVR, were assessed. Statistical analysis included Mann-Whitney test, Kruskal-Wallis test, t-test, Spearman's correlation coefficient and Fisher's exact test. RESULTS:Median LCN2 was significantly higher in the RRD group as compared to control (p2 quadrants, p<0.001) as well as with duration of symptoms (rs = 0.87, p<0.001). After multivariate linear regression analysis, only PVR was independently related with LCN2 concentration. In particular, increased PVR grading was associated with increased LCN2 concentration (coefficient b = 2.97, 95% confidence interval = 1.89 to 4.67, p<0.001). CONCLUSION:A positive correlation between vitreous levels of LCN2 and PVR grading reveals a potential role in the pathogenesis and progression of PVR. Further studies could elucidate if LCN2 could be a therapeutic target.